SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC TO-C - Written communication relating to an issuer or third party:
SEC Accession No. 0001140361-22-025703
Filing Date
2022-07-11
Accepted
2022-07-11 15:46:22
Documents
6

Document Format Files

Seq Description Document Type Size
1 SC TO-C ny20004741x1_8k.htm SC TO-C 42233
2 EXHIBIT 2.1 ny20004741x1_ex2-1.htm EX-2.1 608739
3 EXHIBIT 10.1 ny20004741x1_ex10-1.htm EX-10.1 72645
4 EXHIBIT 99.1 ny20004741x1_ex99-1.htm EX-99.1 23303
5 ny20004741x1_ex99-1logo1.jpg GRAPHIC 7696
6 ny20004741x1_ex99-1logo2.jpg GRAPHIC 2963
  Complete submission text file 0001140361-22-025703.txt   763665
Mailing Address 201 JONES ROAD, SUITE 400 WALTHAM MA 02451
Business Address 201 JONES ROAD, SUITE 400 WALTHAM MA 02451 617-715-3600
LA JOLLA PHARMACEUTICAL CO (Subject) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-C | Act: 34 | File No.: 005-44849 | Film No.: 221076885
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 1350 OLD BAYSHORE HIGHWAY SUITE 400 BURLINGAME CA 94010
Business Address 1350 OLD BAYSHORE HIGHWAY SUITE 400 BURLINGAME CA 94010 6502389600
Innoviva, Inc. (Filed by) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-C
SIC: 2834 Pharmaceutical Preparations